Drugs Made In America Acquisition Corp. Ordinary Shares DMAA · News

website

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a...

Price10.89

Market Cap264.38 M

Float19.79 M

CountryUS

SectorFinancial Services

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

FEATURED

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA)

NEW YORK, July 21, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is

Summary

Jul 21, 2026, 1:54 PM ·PRNewswire